We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

VEDA LAB

VEDALAB focuses on the development, production and marketing of in vitro immunodiagnostic reagents and instruments. I... read more Featured Products: More products

Download Mobile App





Vedalab Presents Wide Range of Quantitative Rapid Tests

By LabMedica International staff writers
Posted on 13 Nov 2023
Print article
Image: Vedalab is exhibiting at MEDICA 2023 at booth number n°1A64, Hall 1 (Photo courtesy of Vedalab)
Image: Vedalab is exhibiting at MEDICA 2023 at booth number n°1A64, Hall 1 (Photo courtesy of Vedalab)

Vedalab (Cerisé, France) is presenting its wide range of lateral flow qualitative rapid tests and rapid tests for home use alongside its new generation rapid test reader at MEDICA 2023.

Vedalab offers several rapid tests for drugs of abuse detection (one drug/test) for home use including cannabinoid, cocaine, opiates, amphetamines and methamphetamines. These tests are to be used with urine samples. Vedalab also offers an immunochromatographic rapid test for the qualitative detection of respiratory syncytial virus (RSV) and influenza A and B viruses in nasal or nasopharyngeal swab samples. This is in addition to its immunochromatographic rapid test for the quantitative detection of anti-spike (S1) IgM and IgG antibodies to SARS-CoV-2 virus in human whole blood, plasma, or serum samples. When used in combination with the VEDALAB Easy reader+ instrument, it can detect and quantify IgM and IgG antibodies to the spike SARS-CoV-2 protein produced after virus infection in human serum, plasma, or finger prick whole blood samples.

At MEDICA 2023, Vedalab is demonstrating the Easy reader+ POC reader that allows quantitative measurements from fingerprick whole blood samples using rapid lateral flow tests. The instrument includes the most advanced and up-to-date technologies (touch screen, enhanced memory, and internet upgrading). The quantitative lateral flow immunochromatography analyzer is intended to provide a quantitative immunochromatography assay result for a wide range of otherwise purely qualitative rapid test devices to increase the accuracy and efficiency of the home, point of care, and laboratory testing of the relevant marker analytes.

Related Links:
Vedalab 

Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Gold Member
Blood Gas Analyzer
GEM Premier 7000 with iQM3
New
Celiac Disease Test
AESKULISA tTg-A New Generation
New
Gold Member
Chagas Disease Test
CHAGAS Cassette

Print article

Channels

Molecular Diagnostics

view channel
Image: Umbilical cord blood biomarkers may improve preterm infant care (Photo courtesy of Shutterstock)

Umbilical Cord Blood Test Could Identify Preterm Infants at Risk for Medical Complications

Advancements in medical technology and neonatology have significantly improved the care of prematurely born infants. However, these infants still face heightened risks for medical complications, such as... Read more

Immunology

view channel

3D Bioprinted Gastric Cancer Model Uses Patient-Derived Tissue Fragments to Predict Drug Response

Tumor heterogeneity presents a major obstacle in the development and treatment of cancer therapies, as patients' responses to the same drug can differ, and the timing of treatment significantly influences prognosis. Consequently, technologies that predict the effectiveness of anticancer treatments are essential in minimizing... Read more

Microbiology

view channel
Image: The Cytovale System isolates, images, and analyzes cells (Photo courtesy of Cytovale)

Rapid Sepsis Diagnostic Test Demonstrates Improved Patient Care and Cost Savings in Hospital Application

Sepsis is the leading cause of death and the most expensive condition treated in U.S. hospitals. The risk of death from sepsis increases by up to 8% for each hour that treatment is delayed, making early... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.